141 related articles for article (PubMed ID: 28093224)
21. CT scanning-based phenotypes vary with ADRB2 polymorphisms in chronic obstructive pulmonary disease.
Kim WJ; Oh YM; Sung J; Lee YK; Seo JB; Kim N; Kim TH; Huh JW; Lee JH; Kim EK; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Kwon SY; Lee SD
Respir Med; 2009 Jan; 103(1):98-103. PubMed ID: 18789663
[TBL] [Abstract][Full Text] [Related]
22. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
[TBL] [Abstract][Full Text] [Related]
23. Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.
Stanford RH; Nag A; Mapel DW; Lee TA; Rosiello R; Vekeman F; Gauthier-Loiselle M; Duh MS; Merrigan JF; Schatz M
Ann Am Thorac Soc; 2016 Jul; 13(7):1067-75. PubMed ID: 27070274
[TBL] [Abstract][Full Text] [Related]
24. Cigarette smoking, carrier state of A or G allele of 46A>G and 79C>G polymorphisms of beta2-adrenergic receptor gene, and the risk of coronary artery disease.
Zak I; Sarecka-Hujar B; Krauze J
Kardiol Pol; 2008 Apr; 66(4):380-6; discussion 387. PubMed ID: 18473266
[TBL] [Abstract][Full Text] [Related]
25. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
26. ADRB2 Gly16Arg polymorphism, asthma control and lung function decline.
Rebordosa C; Kogevinas M; Guerra S; Castro-Giner F; Jarvis D; Cazzoletti L; Pin I; Siroux V; Wjst M; Antò JM; de Marco R; Estivill X; Corsico AG; Nielsen R; Janson C
Eur Respir J; 2011 Nov; 38(5):1029-35. PubMed ID: 21436355
[TBL] [Abstract][Full Text] [Related]
27. [Role of antibiotherapy in acute exacerbation of chronic obstructive pulmonary disease].
Cavassini M; Calandra T; Bridevaux PO
Rev Med Suisse; 2007 Apr; 3(106):939-42. PubMed ID: 17575969
[TBL] [Abstract][Full Text] [Related]
28. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
Bleecker ER; Postma DS; Lawrance RM; Meyers DA; Ambrose HJ; Goldman M
Lancet; 2007 Dec; 370(9605):2118-25. PubMed ID: 18156033
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers that predict and guide therapy for exacerbations of chronic obstructive pulmonary disease.
Brightling CE
Ann Am Thorac Soc; 2013 Dec; 10 Suppl():S214-9. PubMed ID: 24313775
[TBL] [Abstract][Full Text] [Related]
30. Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case-control study.
Serafino-Agrusa L; Scichilone N; Spatafora M; Battaglia S
Pulm Pharmacol Ther; 2016 Apr; 37():89-94. PubMed ID: 26996272
[TBL] [Abstract][Full Text] [Related]
31. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
Wurst KE; Shukla A; Muellerova H; Davis KJ
COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
[TBL] [Abstract][Full Text] [Related]
32. Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations.
Pauwels RA
Proc Am Thorac Soc; 2004; 1(2):73-6. PubMed ID: 16113416
[TBL] [Abstract][Full Text] [Related]
33. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Hanania NA
Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
[TBL] [Abstract][Full Text] [Related]
34. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1.
Brøgger J; Steen VM; Eiken HG; Gulsvik A; Bakke P
Eur Respir J; 2006 Apr; 27(4):682-8. PubMed ID: 16585076
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
36. Leveraging electronic health records to assess the role of ADRB2 single nucleotide polymorphisms in predicting exacerbation frequency in asthma patients.
Sood N; Connolly JJ; Mentch FD; Vazquez L; Sleiman PMA; Hysinger EB; Hakonarson H;
Pharmacogenet Genomics; 2018 Nov; 28(11):256-259. PubMed ID: 30334910
[TBL] [Abstract][Full Text] [Related]
37. Arginine 16 glycine beta2-adrenoceptor polymorphism and cardiovascular structure and function in patients with heart failure.
Wolk R; Snyder EM; Somers VK; Turner ST; Olson LJ; Johnson BD
J Am Soc Echocardiogr; 2007 Mar; 20(3):290-7. PubMed ID: 17336757
[TBL] [Abstract][Full Text] [Related]
38. Home dampness, beta-2 adrenergic receptor genetic polymorphisms, and asthma phenotypes in children.
Wang IJ; Tsai CH; Kuo NW; Chiang BL; Tung KY; Lee YL
Environ Res; 2012 Oct; 118():72-8. PubMed ID: 22883364
[TBL] [Abstract][Full Text] [Related]
39. Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics?
Miravitlles M; Anzueto A
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28644389
[TBL] [Abstract][Full Text] [Related]
40. β
Karimi L; Lahousse L; Ghanbari M; Terzikhan N; Uitterlinden AG; van der Lei J; Brusselle GG; Stricker BH; Verhamme KMC
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31683975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
